Browsing by Author Breast International Group, Brussels, Belgium.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 1 of 1
Issue DateTitleAuthor(s)
2023Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trialAzambuja, Evandro de; Agostinetto, Elisa; Procter, Marion Jennifer; Eiger, Daniel; Pondé, Noam Falbel; Guillaume, Sébastien; Parlier, Damien; Lambertini, Matteo; Desmet, Antoine; Caballero, Carmela Isabel; Jerusalém, Guy; Walshe, J. M.; Frank, E.; Bines, José; Loibl, Sibylle; Gebhart, Martine Piccart; Ewer, Michael S.; Dent, Susan Faye; Plummer, Chris; Suter, Thomas; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic; Frontier Science, Kincraig, Kingussie, UK.; F.Hoffmann-La Roche Ltd, Basel, Switzerland.; Clinical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.; Breast International Group, Brussels, Belgium.; CHU Liege and Liege University, Liege, Belgium.; Cancer Trials Ireland, St Vincent's University Hospital, Dublin, Ireland.; Dana-Farber Cancer Institute, Boston, USA.; Instituto Nacional de Cancer, INCA, Rio de Janeiro, Brazil.; German Breast Group, Neu-Isenburg, Germany.; University of Texas, MD Anderson Cancer Center, Houston.; Duke Cancer Institute, Duke University, Durham, USA.; Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Cardiology, Cardio-Oncology, Bern University Hospital, Bern, Switzerland.
Showing results 1 to 1 of 1